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Abstract Proteolytic processing of the amiloride-sensitive
epithelial sodium channel (ENaC) by serine proteases is
known to be important for channel activation. Inappropriate
ENaC activation by proteasesmay contribute to the pathophys-
iology of cystic fibrosis and could be involved in sodium
retention and the pathogenesis of arterial hypertension in the
context of renal disease. We hypothesized that in addition to
serine proteases, cathepsin proteases may activate ENaC. Ca-
thepsin proteases belong to the group of cysteine proteases and
play a pathophysiological role in inflammatory diseases. Under
pathophysiological conditions, cathepsin-S (Cat-S) may reach
ENaC in the apical membrane of epithelial cells. The aim of
this study was to investigate the effect of purified Cat-S on
human ENaC heterologously expressed in Xenopus laevis
oocytes and on ENaC-mediated sodium transport in cultured
M-1 mouse renal collecting duct cells. We demonstrated that
Cat-S activates amiloride-sensitive whole-cell currents in
ENaC-expressing oocytes. The stimulatory effect of Cat-S
was preserved at pH 5. ENaC stimulation by Cat-S was asso-
ciated with the appearance of a γENaC cleavage fragment at
the plasma membrane indicating proteolytic channel activa-
tion. Mutating two valine residues (V182 and V193) in the
critical region of γENaC prevented proteolytic activation of
ENaC by Cat-S. Pre-incubation of the oocytes with the Cat-S
inhibitor morpholinurea-leucine-homophenylalanine-vinylsul-
fone-phenyl (LHVS) prevented the stimulatory effect of Cat-S
on ENaC. In contrast, LHVS had no effect on ENaC activation
by the prototypical serine proteases trypsin and chymotrypsin.
Cat-S also stimulated ENaC in differentiated renal epithelial
cells. These findings demonstrate that the cysteine protease
Cat-S can activate ENaC which may be relevant under patho-
physiological conditions.
Keywords Epithelial sodium channel (ENaC) . Proteolytic
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Abbreviations
ENaC Epithelial sodium channel
Cat-S Cathepsin-S




The epithelial sodium channel (ENaC) is localized in the
apical membrane of the aldosterone-sensitive distal nephron,
distal colon, respiratory epithelia, and ducts of salivary and
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sweat glands. In these epithelia, ENaC is the rate-limiting
transport mechanism for sodium absorption.
ENaC is a member of the ENaC/degenerin family of non-
voltage-gated ion channels which also includes the acid-
sensing ion channel ASIC1. The available crystal structure
of chicken ASIC1 [9, 29, 50] and recent atomic force
microscopy data of ENaC [49] suggest that ENaC is a
heterotrimer composed of three homologous subunits α, β,
and γ. Each subunit of ENaC contains two transmembrane
domains, a large extracellular domain, and short intracellu-
lar amino and carboxyl termini. In humans, an additional δ-
subunit exists which can functionally replace the α-subunit
in heterologous expression systems [20, 30, 54, 56].
A unique feature of ENaC regulation is its proteolytic
processing thought to be critical for channel activation under
(patho-)physiological conditions [32, 47]. However, the
precise molecular mechanisms of proteolytic channel acti-
vation remain a matter of debate. The channel is thought to
be in its mature and active form in its cleaved state, but there
is evidence for the simultaneous presence of both cleaved
and non-cleaved ENaC in the plasma membrane. Proteases
activate ENaC by cleaving specific sites in the extracellular
domains of the α-, γ-, and δ-subunit but not the β-subunit
[1, 17, 20, 28, 44, 47]. Cleavage probably results in the
release of inhibitory peptides thereby activating the channel
by a change in its conformation [21, 32]. Intracellular pro-
teolytic cleavage by furin [27] at three distinct furin sites
(two in the α-subunit and one in the γ-subunit) is thought to
be important for ENaC maturation during the biosynthetic
pathway before the channel reaches the plasma membrane
[32]. The second and final activating cleavage event proba-
bly takes place at the plasma membrane where γENaC is
cleaved by membrane-bound proteases and/or extracellular
proteases in a region distal to the furin site [1, 10, 17, 23]. It
has also been reported that proteases may indirectly affect
ENaC activity [3, 16]. There is convincing evidence that
several serine proteases (e.g., channel-activating proteases
(CAP1–3), furin, trypsin, chymotrypsin, plasmin, neutrophil
elastase, kallikrein) can proteolytically activate ENaC [47].
In addition to serine proteases, other groups of proteases
may be involved in proteolytic ENaC activation. Indeed,
recent data demonstrate that co-expression of ENaC and
the metalloproteinase meprin β leads to proteolytic activa-
tion of rat ENaC [19]. However, at present, the (patho-
)physiologically relevant proteases for ENaC activation re-
main to be determined and may differ from tissue to tissue.
Recently, we and others reported that plasmin can pro-
teolytically activate ENaC [41, 52]. Inappropriate ENaC
activation by locally generated proteases may be relevant
in several diseases. For example, in the kidney luminal
ENaC activation by urinary plasmin — generated from
filtered plasminogen which is catalyzed by urokinase-type
plasminogen activator — may contribute to renal sodium
retention in nephrotic syndrome [52]. Furthermore, enhanced
ENaC activity by locally released proteases (e.g., human
neutrophil elastase) may aggravate pulmonary symptoms in
patients with cystic fibrosis during an inflammatory response
to acute respiratory infection [25, 45]. Interestingly, the metal-
loproteinases meprins are expressed by leukocytes of the
intestinal immune system [15]. Thus, ENaC activation by
meprin may occur in inflammatory bowel disease. These
examples illustrate a possible pathophysiological role of pro-
teolytic ENaC activation in the context of inflammatory dis-
eases. Organ-specific expression of proteases and differences
in proteolytic ENaC processing may be responsible for the
development of distinct disease phenotypes.
Proteases are classified according to their catalytic active
center into six groups: aspartate, glutamic acid, metallo,
serine, threonine, and cysteine proteases. Human cysteine
proteases such as cathepsins are known to play an important
role in a variety of inflammatory/immune diseases and have
a wide range of (patho-)physiological effects [5, 37, 46]. In
general, cysteine proteases are secreted by macrophages and
epithelial cells during injury and disease. Cathepsins, a
family of 11 proteases in humans, may play a pathophysio-
logical role in many inflammatory diseases [11, 48]. Under
pathophysiological conditions, cathepsin-S (Cat-S) could
reach ENaC in the apical membrane of epithelial cells. For
example, Cat-S is secreted into the colonic lumen during
colitis and may reach ENaC expressed in the apical mem-
brane of colonic epithelial cells [11]. Similarly, ENaC in the
distal nephron may be exposed to Cat-S which may be
present in the tubular fluid in inflammatory renal disease.
The aim of this study was to test the effect of purified Cat-S
on human ENaC heterologously expressed in X. laevis
oocytes and on ENaC-mediated sodium transport in cultured
M-1 mouse renal collecting duct cells.
Material and methods
Chemicals
Amiloride hydrochloride and α-chymotrypsin from bovine
pancreas (type II) were purchased from Sigma. Human
neutrophil elastase (hNE) was obtained from Serva Electro-
phoresis. To prevent contamination of hNE with serine
proteases, we always applied hNE in the presence of the
serine protease inhibitor aprotinin (Sigma, 10 μM) which
does not inhibit neutrophil elastase [1]. Pro-Cat-S was acti-
vated by incubation in activation buffer (NaOAc 0.1 M,
NaCl 0.1 M, EDTA 5 mM, DTT 1 mM, pH 4.5) at 37 °C
for 15 to 30 min (incubation time is batch dependent and
determined by measuring the time to peak activity using the
assay conditions below). The Cat-S was then buffer-
exchanged into PBS (Dulbecco’s phosphate buffered saline
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pH 7.4, Sigma) using an Econo-Pac 10DG column (Bio-Rad).
The active site concentration of Cat-S was determined by
titration with E-64 (3-carboxy-trans-2,3-epoxypropyl-leucyla-
mido(4-guanidino)butane) (Sigma) in a buffer of 0.1 M Na
phosphate, 0.1 MNaCl, 0.1 % PEG-4000, 1 mMDTT, pH 6.5
using 100 μM boc-Val-Leu-Lys-AMC (Bachem) as substrate
and monitoring fluorescence at 390 nm excitation and 460 nm
emission. The Cat-S stock solution prepared in PBS was
diluted to the working concentration in ND96 solution. An
irreversible Cat-S inhibitor (morpholinurea-leucine-homophe-
nylalanine-vinyl phenyl sulfone — LHVS) [2] was used to
inhibit the effect of Cat-S on ENaC. Cat-S and LHVS were
provided by Medivir AB.
Peptide
A 23-mer γENaC peptide was synthesized and purified by
the Peptide Synthesis Core Facility (University of Calgary,
Canada) (purity>95 %). The peptide sequence (176-
TGRKRKVGGSIIHKASNVMHIES-198) corresponds to
the amino acid sequence T176 to S198 of the extracellular
domain of γENaC thought to be critical for proteolytic
channel activation.
Plasmids
Full-length cDNAs for human wild-type (wt) α-, β-, and
γENaC were kindly provided by Harry Cuppens (Leuven,
Belgium). They were subcloned into pcDNA3.1 vector, and
linearized plasmids were used as templates for cRNA synthe-
sis (mMessage mMachine) using T7 as promoter as described
previously [20, 45]. γV182G;V193G mutant was generated by
site-directed mutagenesis (QuikChange® Site-Directed Muta-
genesis Kit, Stratagene) and sequences were confirmed (LGC
Genomics).
Isolation of oocytes and injection of cRNA
Oocytes were obtained from adult female X. laevis in accor-
dance with the principles of German legislation, with ap-
proval by the animal welfare officer for the University of
Erlangen-Nürnberg and under the governance of the state
veterinary health inspectorate (permit no. 621–2531.32-05/
02). Animals were anesthetized in 0.2 % MS222 and ovar-
ian lobes were obtained through a small abdominal incision.
After suture, the animals were allowed to recover fully in a
separate tank before they were returned to the frog colony
1 day later. Oocytes were isolated from the ovarian lobes by
enzymatic digestion at 19 °C for 3–4 h with 600–700 U/ml
type 2 collagenase from Clostridium histolyticum (CLS 2,
Worthington) dissolved in a solution containing (in mM)
NaCl 82.5, KCl 2, MgCl2 1, and HEPES 1 (pH 7.4 with
NaOH). Defolliculated stage V–VI oocytes were injected
(Nanoject II automatic injector, Drummond) with 0.2 ng
cRNA per ENaC subunit, unless stated otherwise. The
cRNAs were dissolved in RNase-free water and the total
volume injected was 46 nl. Injected oocytes were stored at
19 °C in low sodium solution (in mM: N-methyl-D-gluc-
amine-Cl 87, NaCl 9, KCl 2, CaCl2 1.8, MgCl2 1, HEPES 5,
pH 7.4 with Tris) supplemented with 100 U/ml penicillin
and 100 μg/ml streptomycin.
Two-electrode voltage clamp
Oocytes were routinely studied 2 days after injection using
the two-electrode voltage clamp technique essentially as
described previously [20, 45]. Individual oocytes were
placed in a small experimental chamber and constantly
superfused with high sodium solution ND96 (in mM: NaCl
96, KCl 2, CaCl2 1.8, MgCl2 1, HEPES 5, pH 7.4 with Tris)
supplemented with amiloride (2 μM) at a rate of 2–3 ml/min
at room temperature. For acidic pH, we used a solution
containing in mM: NaCl 96, KCl 2, CaCl2 1.8, MgCl2 1,
MES 5, pH 5.0 with Tris. Bath solution exchanges were
controlled by a magnetic valve system (ALA BPS-8) in
combination with a TIB14 interface (HEKA). Voltage clamp
experiments were performed using an OC-725 C amplifier
(Warner Instruments Corp.) interfaced via a LIH-1600
(HEKA) to a PC with PULSE 8.67 software (HEKA) for
data acquisition and analysis. Oocytes were clamped at a
holding potential of −60 mV. Downward current deflections
in the current traces correspond to inward currents, i.e.,
movement of positive charge from the extracellular side into
the cell. Amiloride-sensitive whole-cell currents (ΔIami)
were determined by washing out amiloride with amiloride-
free ND96 and subtracting the whole-cell currents measured
in the presence of amiloride from the corresponding whole-
cell currents recorded in the absence of amiloride. ΔIami was
determined twice in a single oocyte, i.e., before and after
exposure to a test solution. To recover from the first measure-
ment of ΔIami, the oocyte was placed for 5 min in ND96.
Subsequently, the oocyte was transferred to 150 μl of test
solution (protease- and/or inhibitor-supplemented ND96 or
protease-free ND96 solution as control) and was incubated
for 30 min before ΔIami was determined for the second time.
Detection of ENaC cleavage products at the cell surface
Biotinylation experiments were performed essentially as
previously described [20, 45] using 30 oocytes per group.
All biotinylation steps were performed at 4 °C. In some
experiments, oocytes were pre-incubated for 30 min either
in ND96 solution or in ND96 solution containing chymo-
trypsin (2 μg/ml), Cat-S (1 μM), or combination of Cat-S
(1 μM) and LHVS (5 μM). After washing the oocytes three
times with ND96 solution, they were incubated in the
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biotinylation buffer (in mM: triethanolamine 10, NaCl 150,
CaCl2 2, EZ-link sulfo-NHS-SS-Biotin (Pierce) 1 mg/ml, pH
9.5) for 15 min with gentle agitation. The biotinylation reac-
tion was stopped by washing the oocytes twice for 5 min with
quench buffer (in mM: glycine 192, Tris–Cl 25, pH 7.5).
Subsequently, the oocytes were lysed by passing them through
a 27-gauge needle in lysis buffer (in mM: NaCl 500, EDTA 5,
Tris–Cl 50, pH 7.4) supplemented with protease inhibitor
cocktail (“Complete Mini EDTA-free” protease inhibitor
cocktail tablets, Roche Diagnostics) according to the manu-
facturer’s instructions. The lysates were centrifuged for
10 min at 1,500×g. Supernatants were transferred to 1.5-ml
Eppendorf tubes and incubated with 0.5 % Triton X-100 and
0.5 % Igepal CA-630 for 20 min on ice. Biotinylated proteins
were precipitated with 100 μl of Immunopure immobilized
Neutravidin beads (Pierce) washed with lysis buffer. After
overnight incubation at 4 °C with overhead rotation, the tubes
were centrifuged for 3 min at 1,500×g. Supernatants were
removed, and beads were washed three times with lysis buffer.
One hundred microliters of 2× SDS-PAGE sample buffer
(Rotiload 1, Roth) was added to the beads. Samples were
boiled for 5 min at 95 °C and centrifuged for 3 min at
20,000×g before loading the supernatants on a 10 % SDS-
PAGE. To detect γENaC cleavage fragments, we used a
subunit specific antibody against human γENaC at a dilution
of 1:10,000 [20]. Horseradish peroxidase-labeled secondary
goat anti-rabbit antibody (Santa Cruz Biotech) was used at a
dilution of 1:50,000. Chemiluminescence signals were
detected using ECL Plus (Amersham, GE Healthcare). Den-
sitometric analysis was done with ImageJ 1.38x (National
Institutes of Health).
Cell culture
The M-1 mouse renal collecting duct cell line (ATCC
2038CRL, American Type Culture Collection, Rockville,
MD, USA) was established by Dr G. Fejes Tóth [51]. Cells
were used from passage 27 to 29 and were handled as
described previously [4, 16, 52]. Cells were maintained in
a 5 % CO2 atmosphere at 37 °C in PC1 culture medium
(Lonza, Verviers, Belgium) supplemented with 2 mM glu-
tamine, 100 U/ml penicillin, and 100 μg/ml streptomycin.
For transepithelial studies, cells were seeded onto permeable
Millicell-HA culture plate inserts (Millipore GmbH,
Schwalbach, Germany). Cells were grown to confluence
and equivalent short-circuit current (ISC) measurements
were performed in Ussing chambers essentially as described
previously [4, 52]. To minimize ENaC activation by endog-
enous proteases, the confluent M-1 cells grown on filters
were pre-incubated for 4 to 6 h before the experiment with
the broad spectrum serine protease inhibitor nafamostat
mesylate/FUT-175 (Tocris, Bristol, UK) which was added
to the apical bath solution. A 10-mM stock solution of
nafamostat mesylate was prepared in H2O and stored at
−20 °C. Before the experiment, the 10-mM stock was again
diluted to 100 μM in 0.9 % NaCl. The final concentration of
nafamostat mesylate applied to the cells was 1 μM.
High-performance liquid chromatography (HPLC)
and matrix-assisted laser desorption ionization-time
of flight analysis (MALDI-TOF)
23-mer γENaC peptide (500 μM) was incubated with 1 μM
Cat-S in 50 mM Tris–HCl, pH 7.4, for 30 min at 37 °C.
Products were separated by reversed-phase HPLC and iden-
tified using MALDI-TOF. Mass spectrometry data were
provided by the Bio-Organic Biomedical Mass Spectrome-
try Resource at UCSF (A.L. Burlingame, Director) sup-
ported by the Biomedical Research Technology Program
of the NIH National Center for Research Resources, NIH
NCRR P41RR001614 and 1S10RR014606.
Statistical methods
Data are presented as mean±SEM. N indicates the number
of different batches of oocytes, and n the number of indi-
vidual oocytes studied. Statistical significance was assessed
by an appropriate version of Student’s t test with GraphPad
Prism 5.04 (GraphPad Software) for Windows.
Results
Cat-S stimulates ENaC currents in X. laevis oocytes
expressing human ENaC
With the exception of meprin β, only serine proteases have
been shown to activate ENaC. Using the two-electrode
voltage clamp technique, we investigated whether the cys-
teine protease Cat-S can also activate ENaC. We determined
amiloride-sensitive whole-cell currents (ΔIami) of individual
ENaC-expressing oocytes before and after 30 min of incuba-
tion of the oocytes in Cat-S, chymotrypsin, or protease-free
solution. Chymotrypsin (2 μg/ml) is a prototypical serine
protease known to elicit a near maximal stimulatory effect on
ENaC [12]. Figure 1a–c shows six representative whole-cell
current traces from one batch of oocytes. Each individual
oocyte was measured twice, i.e., before and after a 30-min
exposure to protease-free solution (Fig. 1a), to Cat-S (Fig. 1b),
or to chymotrypsin (Fig. 1c) solution. In Fig. 1d, the initial
ΔIami values measured in one batch of oocytes were connected
by lines to the corresponding values measured after 30 min.
Exposure to Cat-S or chymotrypsin increased ΔIami in each
oocyte measured. In contrast, in control experiments, a 30-min
incubation of ENaC-expressing oocytes in protease-free solu-
tion had a negligible effect on ENaC currents (Fig. 1d). In
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conclusion, we demonstrated that Cat-S can activate ENaC
currents in αβγ-human ENaC-expressing oocytes.
Stimulatory effect of Cat-S on human ENaC
is concentration dependent
To investigate the concentration dependence of the Cat-S
effect, we performed experiments using different concentra-
tions of Cat-S (0.01, 0.03, 0.1, 0.3, 1, and 3 μM) (Fig. 2). As
expected, Cat-S increased ΔIami in a concentration-
dependent manner. The effect of 3 μM Cat-S was not larger
than that of 1 μM Cat-S which was the concentration rou-
tinely used in our oocyte experiments. With the Cat-S prep-
arations available for the present study, we could not further
increase the Cat-S concentration.
Activation of ENaC by Cat-S is prevented by the Cat-S
inhibitor LHVS
To confirm that the observed ENaC activation is caused by
the Cat-S activity of the protease preparation used and not
by contamination with a serine protease, we examined the
effect of an irreversible Cat-S inhibitor (LHVS) on proteo-
lytic ENaC activation by recombinant Cat-S. Peptidyl vinyl
sulfones are specific cysteine protease inhibitors of human
cathepsins [6]. The active site cysteine of the cysteine pro-
tease Cat-S covalently binds to the vinylsulfone residue.
This reaction with the target cysteine protease is irreversible.
ΔIami was measured before and after 30 min of incuba-
tion of the oocytes in protease-free solution, in chymotryp-
sin (2 μg/ml), in Cat-S (1 μM), in LHVS (2 μM), or in a
solution containing a combination of Cat-S (1 μM) and
Fig. 1 Cat-S stimulates ENaC currents in Xenopus laevis oocytes express-
ing human ENaC. a–d Oocytes expressing human ENaC were incubated
for 30 min in protease-free solution (control) or in a solution containing
either Cat-S (1 μM) or chymotrypsin (2 μg/ml). Amiloride-sensitive
whole-cell currents (ΔIami) were determined before (−) and after (+)
incubation. Six representative whole-cell current traces from one batch of
oocytes are shown. a–cAmiloride (ami) was present in the bath solution to
specifically inhibit ENaC as indicated by black bars. d Individual ΔIami
values from a representative experiment using one batch of oocytes. Data
points obtained from an individual oocyte are connected by a line
Fig. 2 Stimulatory effect of Cat-S on human ENaC is concentration
dependent. Oocytes expressing human αβγ ENaC were incubated for
30 min in protease-free solution (control), in solutions containing
different concentrations of Cat-S (0.01, 0.03, 0.1, 0.3, 1, and 3 μM)
or in a solution containing chymotrypsin (2 μg/ml). Amiloride-
sensitive whole-cell currents (ΔIami) were detected before (ΔIami ini-
tial) and after incubation (ΔIami 30 min). Columns represent the rela-
tive stimulatory effect onΔIami calculated as the ratio of ΔIami 30 min/
ΔIami initial. Numbers inside the columns indicate the number of
individual oocytes measured. N indicates the number of different
batches of oocytes
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LHVS (5 μM) (Fig. 3). Chymotrypsin and Cat-S had an
average stimulatory effect of about 5.3- and 3.2-fold, re-
spectively. To test whether ENaC activation by Cat-S is
prevented by the Cat-S inhibitor LHVS, the solution con-
taining Cat-S (1 μM) was pre-incubated with the inhibitor
(5 μM) for 10 min. Subsequently, oocytes were incubated
for 30 min in this Cat-S solution containing LHVS before
ENaC currents were measured again. LHVS completely
prevented the stimulation of ENaC currents by recombinant
Cat-S used in our experiments. Incubation of oocytes in
LHVS alone slightly reduced ENaC currents which proba-
bly can be attributed to the well-known phenomenon of
channel “rundown” [53] also observed in control experi-
ments with protease-free solution. The finding that LHVS
prevents ENaC stimulation by the Cat-S preparation used
indicates that the stimulatory effect is mediated by Cat-S.
The Cat-S inhibitor LHVS has no effect on ENaC activation
by the serine proteases chymotrypsin and trypsin
To rule out the possibility that the Cat-S inhibitor LHVS may
have a nonspecific inhibitory effect on serine proteases, we
also tested the effect of LHVS on ENaC activation by the
prototypical serine proteases chymotrypsin and trypsin
(Fig. 4a, b). We measured ΔIami before and after incubation
of the oocytes for 30 min in a protease-free solution, in sol-
utions with different concentrations of chymotrypsin (0.02,
0.2, 2 μg/ml), in LHVS (2 μM), or in solutions containing a
combination of different concentrations of chymotrypsin and
LHVS (2 μM) (Fig. 4a). As expected, exposure to different
concentrations of chymotrypsin increased ΔIami in a
concentration-dependent manner. To investigate the effect of
the Cat-S inhibitor LHVS on ENaC activation by the serine
protease chymotrypsin, solutions containing different concen-
trations of chymotrypsin were pre-incubated with LHVS
(2 μM) for 10 min. Afterwards, the oocytes were incubated
in these chymotrypsin solutions containing LHVS and ΔIami
was determined. In contrast to the inhibition of Cat-S by
administration of LHVS (see Fig. 3), LHVS had no significant
effect on the activation of ENaC by different concentrations of
chymotrypsin. Similar results were obtained using the serine
protease trypsin (Fig. 4b). In summary, these findings indicate
that in the concentration used, LHVS has no inhibitory effect
on the serine proteases chymotrypsin and trypsin. This
Fig. 3 Activation of ENaC by Cat-S is prevented by the Cat-S inhib-
itor LHVS. Oocytes expressing human ENaC were incubated for
30 min in protease-free solution (control), in chymotrypsin (2 μg/ml),
in Cat-S (1 μM), in LHVS (2 μM), or in a solution containing a
combination of Cat-S (1 μM) and LHVS (5 μM). Amiloride-
sensitive whole-cell currents (ΔIami) were determined before (−) and
after (+) incubation. The bar diagram represents normalized average
results obtained in five different batches of oocytes (N05). The indi-
vidual ΔIami values were normalized to the mean ΔIami value of the
ENaC-expressing control group in protease-free solution. Numbers
inside the columns indicate the number of individual oocytes mea-
sured. **p<0.01, ***p<0.001, paired t test
Fig. 4 The Cat-S inhibitor LHVS has no effect on ENaC activation by the
serine proteases trypsin and chymotrypsin. a Oocytes expressing human
ENaC were incubated for 30 min in protease-free solution (control), in
solutions with different concentrations of chymotrypsin (0.02, 0.2, and
2 μg/ml), in LHVS (2 μM), or in solutions containing a combination of
different concentrations of chymotrypsin (0.02, 0.2, and 2 μg/ml) and
LHVS (2 μM). Amiloride-sensitive whole-cell currents (ΔIami) were
determined before (−) and after (+) incubation. Columns represent relative
stimulatory effect onΔIami calculated as the ratio ofΔIami measured after
30 min of incubation (ΔIami 30 min) to the initial ΔIami (ΔIami initial)
measured before incubation. Numbers inside the columns indicate the
number of individual oocytes measured. b Similar experiment as shown
in a using the serine protease trypsin (2 μg/ml) instead of chymotrypsin
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demonstrates that the inhibitory effect of LHVS on ENaC
activation by Cat-S is specific and not caused by contamination
with serine proteases.
Cat-S can activate ENaC in an acidic environment
Inflammation is often associated with tissue acidification
(pH values from 5 to 6) and the activity of proteases is
known to be pH sensitive. To test whether Cat-S can also
activate ENaC in an acidic environment, we performed
similar experiments as described in Fig. 1 and exposed
matched groups of oocytes either to pH 7.4 or to pH 5
(Fig. 5). Extracellular pH has been reported to affect ENaC
activity by complex mechanisms [13, 14]. However, in the
experiments summarized in Fig. 5a, baseline ΔIami values of
ENaC-expressing oocytes were not significantly different in
the two groups of oocytes. In this set of experiments, the
stimulatory effect of Cat-S on ENaC was about 5.2-fold at
pH 7.4 (Fig. 5b). Importantly, this stimulatory effect of Cat-S
on ENaC activity was largely preserved at pH 5 (4.3-fold). In
contrast, the stimulatory effect of chymotrypsin (0.2 μg/ml)
was almost completely suppressed at pH 5. Our data indicate
that Cat-S can activate ENaC in an acidic environment.
In vitro cleavage analysis of the 23-mer γENaC peptide
suggests that Cat-S may cleave human γENaC
To identify a putative cleavage site(s) for Cat-S, a 23-mer
γENaC peptide (176-TGRKRKVGGSIIHKASNVMHIES-
198) was synthesized that corresponds to a region in the
extracellular domain of γENaC thought to contain cleavage
sites critical for proteolytic channel activation [1] (Fig. 6a).
The 23-mer γENaC peptide was incubated with Cat-S
(1 μM) for 30 min and proteolytic degradation was assessed
using HPLC and MALDI-TOF mass spectrometry (Fig. 6b).
As evidenced by the appearance of several peaks, Cat-S was
able to cleave the 23-mer γENaC peptide at more than one
cleavage site.
Activation of ENaC by Cat-S generates a γENaC cleavage
product at the cell surface indicating proteolytic channel
activation
Proteolytic activation of ENaC is associated with the ap-
pearance of different cleavage products. In addition to a 87-
kDa band for full-length γENaC, a cleavage product of
about 76 kDa appears when γENaC is co-expressed with
α- and βENaC [7, 17, 22, 23, 26, 52]. This 76-kDa cleavage
product results from cleavage of γENaC by endogenous pro-
teases like the Golgi-associated convertase furin at the so-called
furin cleavage site. An additional 67-kDa band can be detected
following a second cleavage event in a region in γENaC distal
to the furin site. This second and functionally relevant final
cleavage step of proteolytic ENaC stimulation is critical for the
activation of membrane resident near-silent channels [17] and
is usually mediated by membrane-bound or extracellular pro-
teases, e.g., by plasmin, chymotrypsin, or trypsin.
Using a biotinylation approach as previously described
[20, 45], we investigated whether ENaC activation by Cat-S
also results in the appearance of this 67-kDa γENaC frag-
ment at the cell surface. For this purpose, ENaC-expressing
oocytes were treated for 30 min with protease-free solution,
chymotrypsin (2 μg/ml), or Cat-S (1 μM) solution. Subse-
quently, the biotinylated γENaC cleavage products were
detected by western blot using a γENaC antibody directed
against an epitope at the C-terminus (Fig. 7). The predominant
γENaC fragment detected at the cell surface of untreated
Fig. 5 Cat-S can activate ENaC in an acidic environment. Oocytes
expressing human ENaC were incubated for 30 min in protease-free
(control), in chymotrypsin (0.2 μg/ml), or in Cat-S (1 μM) solution
with a physiological pH of 7.4 (white columns) or an acidic pH of 5
(black columns). Amiloride-sensitive whole-cell currents (ΔIami) were
determined before (−) and after (+) incubation. a ΔIami values from a
representative experiment using one batch of oocytes. b Summary of
similar experiments as shown in a. Columns represent relative stimu-
latory effect on ΔIami calculated as the ratio of ΔIami measured after
30 min of incubation (ΔIami 30 min) to the initial ΔIami (ΔIami initial)
measured before incubation. Numbers inside the columns indicate the
number of individual oocytes measured. N indicates the number of
different batches of oocytes. *p<0.05, ***p<0.001, unpaired t test
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ENaC-expressing control oocytes had a molecular weight of
about 76 kDa. The signal for full-length γENaC (87 kDa)
usually was not detectable which is in agreement with previ-
ously reported data [17, 22, 23, 52]. As expected, activation of
ENaC by exposure to chymotrypsin resulted in the disappear-
ance of the 76-kDa band and the appearance of a lower size
cleavage fragment with a molecular weight of about 67 kDa.
Interestingly, incubation of the oocytes in Cat-S solution had a
similar effect causing the 76-kDa band to disappear and
producing a cleavage product that appeared slightly smaller
than 67 kDa. These results indicate that Cat-S also causes
cleavage of the γ-subunit distal to the furin cleavage site and
possibly slightly more distal than chymotrypsin.
As the stimulatory effect of Cat-S on ENaC currents was
prevented by the Cat-S inhibitor LHVS, we investigated
whether LHVS also prevented proteolytic cleavage of γENaC.
Therefore, the solution containing Cat-S (1 μM) was pre-
incubated with the inhibitor (5 μM) for 10 min. Subsequently,
oocytes were incubated for 30 min in this Cat-S solution
containing LHVS before cell surface expressed γENaC cleav-
age products were investigated. As shown in Fig. 7, the Cat-S
inhibitor LHVS prevented the generation of the 67-kDa
γENaC cleavage product at the cell surface. Thus, our findings
are consistent with the result that the inhibitor prevented pro-
teolytic activation of ENaC currents by Cat-S.
Mutating two putative neutrophil elastase cleavage sites
(γV182;V193) prevents proteolytic activation of γENaC
by Cat-S
Cat-S is known to preferentially target the amino acids
leucine or valine. Interestingly, there are two valine residues
Fig. 6 In vitro cleavage
analysis of the 23-mer γENaC
peptide suggests that Cat-S may
cleave human γENaC at more
than one cleavage site. a Se-
quence of the 23-mer γENaC
peptide showing putative
cleavage sites for proteolytic
ENaC activation. b The 23-mer
γENaC peptide (500 μM) was
incubated with Cat-S (1 μM)
for 30min and cleavage products
were identified by HPLC and
mass spectrometry. Cat-S de-
graded the 23-mer γENaC pep-
tide showing four products
detected by HPLC
Fig. 7 Activation of ENaC by Cat-S generates a γENaC cleavage
product at the cell surface indicating proteolytic channel activation.
The Cat-S inhibitor LHVS prevented the generation of an additional
cleavage product at the cell surface. Oocytes expressing human ENaC
were incubated for 30 min in protease-free solution (control), in chy-
motrypsin (2 μg/ml), in Cat-S (1 μM), or in a solution containing a
combination of Cat-S (1 μM) and LHVS (5 μM). Expression of
biotinylated γENaC at the cell surface was analyzed by SDS-PAGE.
γENaC was detected with an antibody against the C-terminus of
human γENaC. In non-injected (ni) oocytes, γENaC-specific signals
were absent. “–” indicates an empty lane on the gel. Molecular weight
markers are shown on the left side of the gel. Representative western
blot from one batch of oocytes
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(V182 and V193) located in the region of γENaC where the
final cleavage event is thought to occur that leads to channel
activation. These cleavage sites previously have been de-
scribed as cleavage sites for hNE [1]. To investigate the
functional relevance of these sites for channel activation
by Cat-S, we generated a γENaC construct with a double
mutation γV182G;V193G and tested the effect of hNE or Cat-S
on ENaC currents of oocytes expressing wt αβγENaC or
mutant αβγV182G;V193GENaC. We measured ΔIami in indi-
vidual oocytes before and after 30 min of exposure to
protease-free solution, hNE (10 μg/ml), or Cat-S (1 μM).
Baseline ΔIami values of wt and αβγV182G;V193G mutant
expressing oocytes were of similar size (Fig. 8a). As shown
in Fig. 8b, hNE stimulated ΔIami of wt ENaC-expressing
oocytes to a similar extent as Cat-S. Mutating the relevant
hNE cleavage sites should diminish or prevent activation of
the mutant channel by hNE. Indeed, the stimulatory effect of
hNE was almost completely abolished in αβγV182G;
V193GENaC. Interestingly, the γV182G;V193G mutation also
prevented proteolytic activation of ENaC by Cat-S. In con-
trol experiments, a 30-min incubation of wt and mutant
ENaC-expressing oocytes in protease-free solution had a
negligible effect on ENaC currents. In conclusion, we have
demonstrated that mutating the two valine residues (V182
and V193) prevents the stimulatory effect of Cat-S on ENaC
activation. These data suggest that the putative cleavage
sites V182 and V193 for hNE are also likely cleavage sites
for Cat-S.
Cat-S stimulates ENaC in confluent M-1 mouse collecting
duct cells
In addition to the effect of Cat-S in the oocyte system, we
investigated the effect of Cat-S in cultured M-1 mouse
collecting duct cells known to express ENaC when grown
to confluence in PC1 culture medium containing a high
concentration (5 μM) of dexamethasone [4, 52]. Figure 9a
shows two representative short-circuit current traces. It is
well established that in M-1 cells under the experimental
conditions used, baseline ISC can be attributed to ENaC-
mediated electrogenic sodium transport [4, 16, 24]. In the
upper control trace, baseline ISC shows a typical slow de-
cline over time which is probably caused by spontaneous
channel rundown. Application of vehicle (phosphate buff-
ered saline) resulted in a transient solution exchange artifact
but did not affect baseline ISC. Application of amiloride
(10 μM) largely inhibited ISC which confirmed that it was
mediated by ENaC. In the lower trace, the initial ISC is
similar to that in the control trace. Importantly, apical appli-
cation of Cat-S (2 μM) resulted in a sustained increase in ISC
which remained sensitive to amiloride. This indicates that
the ISC increase observed upon application of Cat-S is
caused by a stimulation of ENaC. The stimulatory response
to Cat-S was observed in all experiments (n07) in which
Cat-S was applied (Fig. 9b). On average, apical application
of Cat-S (2 μM) stimulated ENaC-mediated ISC by about
24 % (Fig. 9c).
Discussion
In the present study, we showed that Cat-S stimulates
ENaC-mediated whole-cell currents in X. laevis oocytes
expressing human ENaC. This stimulation was associated
with the appearance of a γENaC cleavage fragment at the
cell surface indicating proteolytic channel activation. The
stimulatory effect of Cat-S on ENaC activity and the con-
comitant appearance of a γENaC cleavage product at the
cell surface were prevented by the Cat-S inhibitor LHVS. In
Fig. 8 Mutating two putative neutrophil elastase cleavage sites
(γV182;V193) prevents proteolytic activation of γENaC by Cat-S.
Oocytes expressing αβγ (open symbols) or αβγV182G;V193GENaC
(filled symbols) were incubated for 30 min in protease-free solution
(control) or in a solution containing either hNE (10 μg/ml) or Cat-S
(1 μM). Amiloride-sensitive whole-cell currents (ΔIami) were deter-
mined before (−) and after (+) incubation. a Individual ΔIami values
from a representative experiment using one batch of oocytes. Data
points obtained from individual oocytes are connected by a line. b
Summary of similar experiments as shown in a. Columns represent
relative stimulatory effect on ΔIami calculated as the ratio of ΔIami
measured after 30 min of incubation (ΔIami 30 min) to the initial ΔIami
(ΔIami initial) measured before incubation. Numbers inside the col-
umns indicate the number of individual oocytes measured. N indicates
the number of different batches of oocytes
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addition, we demonstrated that Cat-S can stimulate ENaC-
mediated transepithelial sodium transport in differentiated
renal epithelial cells. To our knowledge, this is the first
report that the cysteine protease Cat-S activates ENaC most
likely by proteolytic cleavage of its γ-subunit at the cell
surface. Stimulation of ENaC by locally released Cat-S may
play a pathophysiological role in inflammatory disease, e.g.,
in colitis or nephritis.
As a rate-limiting step for transepithelial Na+ transport,
ENaC is the main target of highly complex regulatory
mechanisms that adjust transepithelial Na+ transport to levels
appropriate for tissue needs and for overall body sodium
homeostasis. In addition to extracellular and intracellular pro-
teases, these mechanisms include hormones (e.g., aldosterone,
angiotensin II, vasopressin, insulin, insulin-like growth factor
I), intra- and extracellular ion concentrations, osmolarity, tu-
bular flow rate, kinases (e.g., serum- and glucocorticoid-
inducible kinase isoform 1, protein kinase A, extracellular-
regulated kinase), and interacting proteins (e.g., ubiquitin
ligases, deubiquitinylating proteases, Rab proteins) [35]. At
present, it is unclear how these mechanisms interact and how
for example the hormonal regulation of ENaC is linked to its
proteolytic activation. In the kidney, aldosterone is thought to
be the main hormonal regulator of ENaC activity. Interesting-
ly, high levels of aldosterone known to activate ENaC activity
in the distal tubule have also been shown to increase proteo-
lytic ENaC cleavage [18, 33, 36]. This stimulatory effect on
ENaC cleavage may be mediated by an aldosterone-induced
expression of prostasin [38]. This example of a possible link
between the hormonal and proteolytic regulation of the chan-
nel makes it likely that other physiological pathways of ENaC
regulation also involve proteases which may include different
types of proteases in a tissue-specific manner.
Most of our knowledge about proteolytic ENaC activa-
tion stems from studies in model systems like X. laevis
oocytes and cultured cells. Recently, functional evidence is
emerging that ENaC activation by extracellular proteases
also occurs in native tissue. Indeed, it has been demonstrat-
ed that trypsin can activate ENaC in microdissected mouse
[39] and rat [18] distal nephron. Moreover, in kallikrein-
deficient mice, the natriuretic effect of amiloride and the
amiloride-sensitive rectal potential difference were found to
be reduced compared to wild-type animals [43]. These
results suggested that kallikrein can activate ENaC which
was confirmed in a recent study using the oocyte expression
system [42].
Interestingly, the stimulatory effect of Cat-S on ENaC
currents was more pronounced in the oocyte expression
system heterologously expressing ENaC than in the M-1
mouse collecting duct cells endogenously expressing ENaC.
This discrepancy is consistent with previously reported find-
ings that baseline ENaC activity in M-1 cells is high which
may result from the culture conditions used. Indeed, to
reveal proteolytic ENaC activation by soluble proteases
applied to the apical surface of M-1 cells, the cells need to
Fig. 9 Cat-S stimulates ENaC in confluent M-1 mouse collecting duct
cells. a Representative equivalent short-circuit current (ISC) recordings
from confluent M-1 cells pretreated with nafamostate mesylate to
reduce constitutive ENaC activation by endogenous proteases. Vehicle
control (phosphate buffered saline, upper trace) or Cat-S (2 μM, lower
trace) was added to the apical bath solution ofM-1 cells. At the end of the
experiment, amiloride (ami; 10 μM) was added apically to confirm that
the stimulated ISC was mediated by ENaC. b, c Summary of results from
similar experiments as shown in a. bData points represent individual ISC
values obtained from six (control) or seven (Cat-S) individual experi-
ments that are connected by a line. c Columns represent relative stimula-
tory effect onΔISC calculated as the ratio ofΔISC measured after 20 min
of incubation (ΔISC 20 min) to the initial ISC (ΔISC initial) measured
before apical addition. **p<0.01, unpaired t test
362 Pflugers Arch - Eur J Physiol (2012) 464:353–365
be pretreated with inhibitors of endogenous proteases. How-
ever, even in pretreated cells, the proteolytic activation of
ENaC by trypsin or plasmin was found to be smaller in M-1
cells than that observed in the oocyte expression system [34,
39, 52]. These findings are consistent with those of the
present study and suggest that constitutive proteolytic acti-
vation of ENaC by endogenous proteases is more complete
in M-1 cells than in the oocyte expression system.
There is convincing evidence that proteolytic processing by
serine proteases in the biosynthetic pathway and at the plasma
membrane is essential for the regulation of ENaC activity [32,
47]. However, to our knowledge so far, no data have been
reported demonstrating an effect of cathepsin proteases or of
other members of the group of cysteine proteases on ENaC
activity. Cysteine proteases are secreted by inflammatory and
epithelial cells during injury and disease. Cat-S is expressed in
the kidney, spleen, lymph nodes, and lung [31] and also by
antigen-presenting cells and macrophages which allow its
secretion in a wide range of different tissues and organs [11,
57]. Cat-S levels in the cerebrospinal fluid have been reported
to be in the low nanomolar range [40]. In contrast, in lyso-
somes, there are some reports demonstrating millimolar levels
of cathepsins [8, 55]. In the kidney, the strongest expression of
Cat-S was detected in proximal tubule cells [31]. During
inflammatory diseases, Cat-S may be secreted by proximal
tubule cells into the urine and hence may reach ENaC in the
distal tubule. Recent data show that Cat-S is selectively acti-
vated in the colonic lumen during colitis [11]. Thus, in the
colonic lumen, Cat-S may also reach epithelial cells express-
ing ENaC at the luminal membrane. However, the concentra-
tion of Cat-S that may be reached at the apical membrane of
epithelial cells in inflammatory disease is not yet known.
We showed that the stimulation of ENaC by Cat-S and
chymotrypsin generates a ~67-kDa γENaC cleavage product
at the cell surface. Previously, a similar 67-kDa γENaC cleav-
age fragment has been described after ENaC activation by
trypsin [17], plasmin [41], neutrophil elastase [22], or by co-
expression of ENaC with prostasin [7]. This suggests that the
cleavage sites in γENaC mediating proteolytic channel acti-
vation by all these proteases including Cat-S are localized in
close vicinity. Putative cleavage sites for prostasin (CAP1)
(γRKRK178, [7]), plasmin (γK189, [41]), and neutrophil
elastase (γV182;γV193, [1]) have been described and are
located distal to the furin cleavage site in the extracellular
domain of the γ-subunit. According to the availability of
proteases in tissues, different protease cleavage sites may be
used in distinct tissues to cleave and activate ENaC.
Physiologically relevant protease cleavage sites are diffi-
cult to predict from the amino acid sequence of a protein since
conformational aspects need to be considered. Cat-S is known
to preferentially target the amino acids leucine or valine. There
are two valine residues in the critical region in γENaC. Thus,
it is possible that Cat-S cleaves in this region. Our mass
spectrometry data suggest that Cat-S may cleave ENaC at
more than one cleavage site in a peptide corresponding to this
critical region of γENaC. Indeed, mutating the two putative
cleavage sites for human neutrophil elastase (V182;V193)
largely abolished the stimulatory effect of Cat-S on ENaC.
Thus, the two valine residues are essential for Cat-S activation
of ENaC and these are likely cleavage sites for Cat-S.
In addition, we have to consider the possibility that ENaC
stimulation by Cat-S is mediated indirectly by its activating
effect on other proteases, e.g., a membrane-bound protease
like prostasin, which in turn proteolytically activate ENaC.
However, ENaC stimulation by Cat-S was preserved at pH 5.
This argues in favor of a direct proteolytic effect of Cat-S on
ENaC, because most serine proteases, including those present
at the plasma membrane of the oocytes, are likely to be
inactive at an acidic pH of 5. Indeed, serine proteases usually
are active at pH 7 to 9, whereas cysteine proteases prefer a pH
range from 3 to 7. Thus, Cat-S is a protease that can proteo-
lytically activate ENaC at acidic pH typical for inflamed tissue
where serine proteases would no longer be functional. In
summary, we demonstrate for the first time that ENaC can
be activated by Cat-S which may be pathophysiologically
relevant in inflammatory disease. This process is mediated
by the neutrophil elastase cleavage sites which therefore play a
key role in proteolytic ENaC activation by Cat-S.
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